Antibody Industrial Symposium
Date: Jun 30-Jul 1, 2026
Location: The CORUM Congress Center Montpellier, France
Booth: 16
JOIN US!
Meet Catalent’s experts at AIS 2026 to explore how our integrated drug substance and drug product solutions can accelerate the development of therapeutic antibodies and complex biologics. Learn how our end‑to‑end capabilities, from cell line development through clinical and commercial manufacturing, help innovators reduce complexity and advance programs with greater speed and confidence.
Complete the form to schedule a meeting with our experts!
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
